2.1. Study selection protocol

WS Waqas Javed Siddiqui
MK Muhammad Yasir Khan
MR Muhammad Shabbir Rawala
KJ Kadambari Jethwani
MK Mohammad Harisullah Khan
CA Chikezie Alvarez
RK Ramsha Kashif
SH Syed Farhan Hasni
SA Sandeep Aggarwal
AK Andrew Kohut
HE Howard Eisen
request Request a Protocol
ask Ask a question
Favorite

We included only those studies for final analysis which met our predefined inclusion criteria.

Inclusion Criteria – 1)Prospective RCT’s, 2) Comparing only DATT to TATT in patients undergoing PCI and also require long-term anti-thrombotic therapy, 3) Adult patients (age ≥ 18 years), 4) All of the following outcomes were addressed: I – Any bleeding (including major and minor), II – thromboembolic events (including ischemic stroke, stent thrombosis or MI), and III – death (cardiac and non-cardiac).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A